These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20006425)

  • 1. Mechanisms of breast cancer bone metastasis.
    Zhang Y; Ma B; Fan Q
    Cancer Lett; 2010 Jun; 292(1):1-7. PubMed ID: 20006425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
    Yoneda T; Hiraga T
    Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
    Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
    Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Encounter of cancer cells with bone. Development of bone metastasis-specific targeting therapy].
    Hayashi S; Hanamura T
    Clin Calcium; 2011 Mar; 21(3):389-96. PubMed ID: 21358060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH analogs reduce invasiveness of human breast cancer cells.
    von Alten J; Fister S; Schulz H; Viereck V; Frosch KH; Emons G; Gründker C
    Breast Cancer Res Treat; 2006 Nov; 100(1):13-21. PubMed ID: 16758121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
    Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
    Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
    Siclari VA; Guise TA; Chirgwin JM
    Cancer Metastasis Rev; 2006 Dec; 25(4):621-33. PubMed ID: 17165131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites.
    Powell GJ; Southby J; Danks JA; Stillwell RG; Hayman JA; Henderson MA; Bennett RC; Martin TJ
    Cancer Res; 1991 Jun; 51(11):3059-61. PubMed ID: 2032246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
    Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T
    Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway.
    Shen X; Qian L; Falzon M
    Exp Cell Res; 2004 Apr; 294(2):420-33. PubMed ID: 15023531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
    Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
    Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
    Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
    Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.